Edgewise elevates chief operating officer, hires development exec
BOULDER — Edgewise Therapeutics Inc. (Nasdaq: EWTX) has promoted Behrad Derakhshan, formerly the Boulder-based muscle disease biopharmaceutical company’s chief business officer, to chief operating officer, and hired Robert Blaustein as chief development officer.
“These leadership changes signify our organization’s progression into late-stage clinical development, setting the stage for the future commercialization of our novel therapeutics,” Edgewise CEO Kevin Koch said in a prepared statement. “As we welcome Rob, it’s an exciting time for the Company, and we are fortunate to have a highly experienced executive team guiding us forward.”
Blaustein previously held leadership positions with pharmaceutical giant Merck & Co. Inc.
(NYSE: MRK).
SPONSORED CONTENT
Edgewise Therapeutics Inc. (Nasdaq: EWTX) has promoted Behrad Derakhshan, formerly the Boulder-based muscle disease biopharmaceutical company’s chief business officer, to chief operating officer, and hired Robert Blaustein as chief development officer.
Related Posts
-
Greeley isn’t the only growing community in its corner of Weld County. Just south on…
-
Broomfield won the Large Community of the Year Award this month during the Economic Development…
-
Cardinal Peak LLC recently promoted Sean O’Neil and Bernard Vachon to the roles of co-CEO.
-
Airplane manufacturer Boeing will eliminate 63 jobs across Colorado operations in Arapahoe, Denver, El Paso…